In a recent study published in Science Advances, researchers evaluated the impact of mucosal versus intramuscular vaccine immunization on airborne infection and transmission of severe acute ...

Harnessing the power of a single dose, this innovative vaccine offers a potent defense against both current and future COVID-19 threats. Study: A single-dose intranasal live-attenuated codon ...

Since SARS-CoV-2 is here to stay, it is important to assess how our understanding of this virus has changed post-pandemic. Dr. Jamie Guenthoer, a staff scientist in the Overbaugh lab at Fred ...

Another round of SARS-CoV-2 booster vaccines are being offered, but will another booster reduce our risk of COVID-19 disease? This is a question on the minds of many, including Dr. Bo Zhang, an ...

Higher immune responses were elicited by mRNA-1083 than high-dose quadrivalent inactivated influenza vaccine for all 4 influenza strains and high-dose quadrivalent inactivated influenza vaccine for 3 ...

Two injections of mRNA-1273, a lipid nanoparticle–encapsulated mRNA-based vaccine produced in collaboration with the NIAID that encodes the SARS-CoV-2 spike protein, conferred protection against Covid ...

Most vaccines are designed to provide immunity against just one pathogen. Vaccines for chicken pox (caused by varicella-zoster virus) were only developed to fight that one disease, for example.

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for the updated formulation of the ...

CAMBRIDGE, MA / ACCESS Newswire / August 27, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License ...